Kilimanjaro Clinical Research Institute (KCRI)

What Kilimanjaro Clinical Research Institute (KCRI) does

Kilimanjaro Clinical Research Institute (KCRI) is a non-profit academic clinical research institute founded in 2009 and headquartered in Moshi, Tanzania, operating as the third cornerstone of the Good Samaritan Foundation alongside Kilimanjaro Christian Medical Centre (KCMC Hospital) and KCMC University. The institute initiates and conducts clinical research across infectious diseases (HIV, TB, malaria, Rift Valley fever, neglected tropical diseases), maternal and child health, oncology, and non-communicable diseases, while providing research training from short courses through PhD supervision. KCRI serves as secretariat of the PanACEA TB clinical trials consortium (12 African sites) and Deputy Director of the EACCR network, and is an IMPAACT and ACTG clinical trial site.

Its core technical infrastructure includes a Tanzania-first 4-star Africa CDC-certified BSL-3 high-containment laboratory, a biotechnology laboratory with molecular and immunology, microbiology, chemistry and hematology, bioinformatics and genomics, sample storage, and zoonosis capabilities, a COBAS PURE high-throughput diagnostics platform, and DHIS2-based digital health registries. KCRI operates without disclosed commercial pricing; revenue is generated almost exclusively through research grants from 15+ international funders (EDCTP, CEPI, NIH, Wellcome Trust, NIHR, UKRI, CIHR, DANIDA, TDR, and others), supplemented by grant-funded training programs and laboratory services delivered to consortium partners. Distribution occurs through consortium membership, direct institutional partnerships with KCMC and 14 regional health facilities, and international academic collaborations with Duke, University College Cork, Karolinska, DTU, and the University of Glasgow.

Name

Kilimanjaro Clinical Research Institute (KCRI)

Legal name

Kilimanjaro Clinical Research Institute

Website

https://kcri.ac.tz

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

KCRI is a Tanzanian non-profit academic clinical research institute that conducts multinational trials and laboratory research in HIV, TB, malaria, cancer, and maternal health, serving as PanACEA secretariat and EACCR Deputy Director with 15+ international funders.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Educational Support Services (61171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Educational Services (8200)

akta.pro industry

PRIMARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGACAF

Investigator & Site Training / GCP Support

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAJAOAM

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)

Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health Initiatives & Partnerships

SECONDARYEDAOAJAO

Clinical Research Support (CRC/CTA)

Education/Vocational, Technical & Trade Education/Healthcare Allied & Clinical Support Training

SECONDARYBPAGACAA

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)

Business & Public Services/Nonprofit, NGO & Social Services/Health & Medical Nonprofits

Keywords

• Clinical research services
• Laboratory diagnostics
• Biomedical research
• Infectious disease research
• Research training programs

Headquarters

HQ city

Moshi

HQ country

Tanzania

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Grant-Funded Research: KCRI operates primarily through research grants from international funding agencies. Major funders include EDCTP, NIH, CEPI, Wellcome Trust, NIHR, and others supporting specific research projects in HIV, TB, malaria, cancer, and other diseases.
2. Training and Education Services: Provides academic attachments, short courses, and research training programs. Conducts workshops for partner organizations and offers professional development opportunities.
3. Laboratory Services: Offers specialized laboratory testing services including viral load testing, molecular diagnostics, and other clinical laboratory analyses for research and healthcare purposes.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

KCRI is a non-profit academic clinical research institute that initiates and conducts clinical trials in HIV, TB, malaria, cancer, maternal and child health, and non-communicable diseases; provides specialized laboratory services (BSL-3 high-containment, molecular, genomics, bioinformatics, microbiology, hematology, immunology, zoonosis); and delivers research training from short courses through PhD supervision. It functions as the secretariat of the PanACEA TB drug development consortium and the Deputy Director of the EACCR network, serving as the third cornerstone of the Good Samaritan Foundation alongside KCMC Hospital and KCMC University.

Product overview

KCRI operates as a clinical research institute providing integrated laboratory services, research facilities, and specialized testing capabilities. The institute offers comprehensive laboratory services (Bioinformatics and Genomics, Chemistry and Hematology, Microbiology, Molecular and Immunology, Sample Storage, Zoonosis), BSL-3 laboratory for high-containment research, radiotherapy cancer treatment services, and supports clinical trials through data management, ethics/regulatory, and training. KCRI serves as secretariat for the PanACEA TB clinical trials consortium across 12 African sites.

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory Services Comprehensive laboratory services including Bioinformatics and Genomics, Chemistry and Hematology, Microbiology Laboratory, Molecular and Immunology, Sample Storage Facilities, and Zoonosis Laboratory, provided to research collaborators and clinical partners.
• Research Facilities and Support Research infrastructure services including data management, clinical trials and monitoring, ethics and regulatory support, grants management, research training, and short courses for academic and clinical collaborators.
• BSL-3 High-Containment Laboratory Services High-containment Biosafety Level 3 laboratory certified by Africa CDC for handling high-risk pathogens, available to research collaborators conducting clinical studies on priority infectious diseases.

Quantifiable outcome

• 106 women screened for breast cancer during NCDs Week commemoration
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

14 partnerships are on record, tiered core and minor.

• PanACEAcoreStrategic or Co-development PartnerKCRI serves as the secretariat of PanACEA (Partnership for New TB Drugs), a clinical trials consortium focused on shortening and simplifying TB therapy. The consortium operates across 12 African sites and is funded for a 5-year period to develop new TB drugs.
• EACCR (East African Consortium for Clinical Research)coreStrategic or Co-development PartnerEDCTP-funded project aiming to integrate and synergize efforts to strengthen research capacity, design, conduct, evaluate and communicate large multi-centre clinical trials under best international practices. Partners include Ethiopia, Germany, Kenya, Netherlands, Sudan, Tanzania, Norway, Sweden, UK, Uganda.
• University College CorkcoreStrategic or Co-development PartnerCollaboration on multiple projects including LINDA-FAMILIA digital health initiative, GOTHOMIS, Surgeon Noonan Society medical equipment donations, and general research partnerships. Prof. Mmbaga holds adjunct position at UCC.
• Duke UniversitycoreStrategic or Co-development PartnerFormal MoU signed between KCMC Hospital, KCMC University, and Duke University. Collaboration includes KCMC-Duke Global Emergency Medicine Innovation and Implementation Research Center (GEMINI) and TRECK trauma research program.
• DTU (Technical University of Denmark)coreStrategic or Co-development PartnerSelf-governing university collaborating on research initiatives. KCRI partners with DTU on various clinical research projects under the PanACEA consortium.
• Karolinska InstitutetcoreStrategic or Co-development PartnerBREEDIME project coordinator. Partnership to build resilient research ethics, diagnostics, and medicines regulatory capacity during routine and public health emergency periods across Tanzania, Rwanda, UK, and Sweden.
• KCMC (Kilimanjaro Christian Medical Centre)coreStrategic or Co-development PartnerPrimary affiliated hospital providing clinical research facilities and patient access. KCRI is positioned as third cornerstone of Good Samaritan Foundation alongside KCMC health services and training. Hospital celebrated 55th anniversary in March 2026.
• Tanzania Veterinary Laboratory Agency (TVLA)coreStrategic or Co-development PartnerPartner in One Health approach research including REMIT project on Rift Valley fever. TVLA develops and markets technological packages and biologicals for animal disease surveillance.
• NIH Fogarty International CentercoreStrategic or Co-development PartnerActing Director Dr. Peter Kilmarx visited KCRI in May 2026 to review NIH-funded collaborations. Strong partnership supporting research capacity and training programs.
• University of GlasgowcoreStrategic or Co-development PartnerREMITE project partner. Vice Principal for Research and Knowledge Exchange visited KCRI in January 2026 to review collaborative initiatives and tour KCRI Biotechnology Laboratory.
• NIMR (National Institute for Medical Research)coreStrategic or Co-development PartnerNational regulator for health research in Tanzania, serving as the research arm of Ministry of Health. BREEDIME project partner. Founded in 1980 with over 100 scientists across Tanzania.
• EcoHealth AllianceminorStrategic or Co-development PartnerActive in 32 countries worldwide working on biosurveillance, conservation efforts, public health policies, and climate change-disease risk connections. Partner in One Health research initiatives.
• Africa CDCcoreStrategic or Co-development PartnerAssessed KCRI for BSL-3 laboratory certification under regulatory framework for institutions handling high-risk pathogens. KCRI became first laboratory in Tanzania to undergo this assessment.
• University College Cork Surgeon Noonan SocietyminorStrategic or Co-development PartnerThrough annual grant support, the Society enables medical equipment donations to KCMC Pediatrics Department including patient monitors, pulse oximeters, and infusion pumps.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Swiss Tropical and Public Health Institute: A European research institution with deep African research collaborations, including DTU and Karolinska-adjacent work. Comparable in conducting clinical trials and capacity building in Sub-Saharan Africa, and a common consortium partner for KCRI's networks.

Direct peers

• MRC/UVRI & LSHTM Uganda Research Unit: An established East African clinical research unit jointly operated with the London School of Hygiene & Tropical Medicine. Comparable to KCRI in conducting HIV/TB clinical trials, hosting EDCTP-funded networks like EACCR, and providing graduate research training.
• Africa Health Research Institute (AHRI): A South African research institute with strong HIV/TB and BSL-3 capabilities. Comparable in hosting NIH-funded clinical trials, training graduate researchers, and operating within a hospital-linked academic model.
• Ifakara Health Institute: A Tanzania-based research institute with similar scope to KCRI, conducting malaria, maternal health, and infectious disease research. Operates as a domestic peer with overlapping themes in vector-borne disease surveillance and community engagement.
• Kenya Medical Research Institute (KEMRI): KEMRI is a leading East African clinical research institute with multiple BSL-3 laboratories and IMPAACT/ACTG trial sites. Like KCRI, it conducts infectious disease research, hosts international consortia, and serves as a regional hub for clinical trials and training.
• Armauer Hansen Research Institute (AHRI Ethiopia): An Ethiopian clinical research institute conducting TB, HIV, and NTD research. Comparable to KCRI as an EDCTP-funded partner within EACCR and similar consortia, with comparable focus on biomedical laboratory and clinical trial infrastructure.
• National Institute for Medical Research (NIMR) Tanzania: Tanzania's national health research body and KCRI's named partner. Comparable in conducting biomedical and clinical research, coordinating multi-site trials, and providing research training within Tanzania.
• Noguchi Memorial Institute for Medical Research: Ghana's leading biomedical research institute with BSL-3 capacity and clinical trial experience. Comparable in operating as a West African BSL-3-enabled research site with international funder relationships and graduate training programs.
• Centre for Infectious Disease Research in Zambia (CIDRZ): A Zambian research organization conducting HIV, TB, and emerging infectious disease trials across multiple sites. Comparable in operating as an African clinical trial site with international funding and graduate research training programs.

Broad incumbents

• South African Medical Research Council (SAMRC): A larger, nationally funded research body with a broader portfolio across all major health research areas. Comparable to KCRI in research training and clinical trial infrastructure but at much greater scale and with a more diversified funding base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/login
• Facebookfacebook.com/kcrimoshi
• LinkedInlinkedin.com/company/kilimanjaro-clinical-research-institute
• Instagraminstagram.com/kcritanzania

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kilimanjaro Clinical Research Institute (KCRI)